etoposide has been researched along with Anoxemia in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (60.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benn, BS; Ivanick, NM; Moh, M; Seeley, EJ | 1 |
| Cai, K; Chen, Q; Hou, Y; Hu, Y; Li, K; Li, M; Li, Y; Luo, Z; Song, G; Xue, C; Zhou, J | 1 |
| Choi, BKA; D'Onofrio, PM; Koeberle, PD; Shabanzadeh, AP | 1 |
| Cao, J; Ding, L; Liang, G; Luo, P; Ma, S; Shi, S; Wang, D; Weng, Q; Yao, Z; Yuan, C; Zhu, H; Zhuang, K | 1 |
| Carver, J; Ky, B; Menachem, J; Offin, MD; Squillante, C; Vaughn, D | 1 |
| Ayene, IS; Li, J; Prendergast, GC; Ward, KM; Zhang, D | 1 |
| Cawthorne, CJ; Demonacos, C; Dive, C; Erler, JT; Koritzinsky, M; Miller, C; Stratford, IJ; Williams, KJ; Wilson, C; Wouters, BG | 1 |
| Banáth, JP; Olive, PL; Sinnott, LT | 1 |
| Honna, T; Kawashima, N; Kitano, Y; Kuroda, T; Matsuda, H; Miyauchi, J; Morikawa, N; Nakano, M; Tanaka, K | 1 |
| Díaz-Montero, CM; McIntyre, BW | 1 |
| Chang, NS; Doherty, J; Ensign, A; Hong, Q; Hsu, LJ; Schultz, L | 1 |
| Han, SK; Kim, YW; Lee, CT; Lee, SM; Shim, YS; Yoo, CG | 1 |
| Cho, C; Cho, DH; Hong, SH; Jung, YK; Kim, HJ; Lee, HJ; Pyo, JO | 1 |
| Biagiotti, T; Carbone, MV; D'Amico, M; Fredducci, D; Giunti, S; Marzi, I; Olivotto, M; Wanke, E | 1 |
| Hussain, M; Ruckdeschel, JC; Zimmerman, MS | 1 |
| Lei, S; Ogiso, Y; Omura, S; Tomida, A; Tsuruo, T | 1 |
| Aller, P; de Blas, E; Fernández, C; Sancho, P; Troyano, A | 1 |
| Boller, YC; Brandes, LM; Kennedy, KA; Lin, ZP; Patierno, SR; Russell, RL | 1 |
| Chang, NS | 1 |
| Hughes, CS; Shen, JW; Subjeck, JR | 1 |
20 other study(ies) available for etoposide and Anoxemia
| Article | Year |
|---|---|
Bilateral Endobronchial Masses and Severe Hypoxemic Respiratory Failure.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Combined Modality Therapy; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Humans; Hypoxia; Lymphoma, B-Cell; Male; Middle Aged; Prednisone; Respiratory Insufficiency; Tomography, X-Ray Computed; Vincristine | 2019 |
Oxygenated theranostic nanoplatforms with intracellular agglomeration behavior for improving the treatment efficacy of hypoxic tumors.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood Substitutes; Drug Carriers; Drug Delivery Systems; Etoposide; Fluorocarbons; Hep G2 Cells; Humans; Hypoxia; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice, Nude; Neoplasms; Theranostic Nanomedicine; Treatment Outcome; Tumor Hypoxia | 2019 |
Stabilization of primary cilia reduces abortive cell cycle re-entry to protect injured adult CNS neurons from apoptosis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Central Nervous System; Cilia; Etoposide; Female; Hypoxia; Neurons; Optic Nerve Injuries; Phosphorylation; Protective Agents; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells | 2019 |
Resistance of SMMC-7721 hepatoma cells to etoposide in hypoxia is reversed by VEGF inhibitor.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Hypoxia; Cell Line, Tumor; Drug Resistance, Neoplasm; Etoposide; Extracellular Signal-Regulated MAP Kinases; Humans; Hypoxia; Liver Neoplasms; NF-kappa B; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Vascular Endothelial Growth Factor A | 2015 |
Association Among Hypoxemia, Patent Foramen Ovale, and Mediastinal Germ Cell Tumor: A Case Report.
Topics: Adult; Antineoplastic Agents; Cisplatin; Drug Therapy, Combination; Etoposide; Foramen Ovale, Patent; Humans; Hypoxia; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Oxygen Inhalation Therapy | 2015 |
Hydroxyethyl disulfide as an efficient metabolic assay for cell viability in vitro.
Topics: Acetaminophen; Arsenicals; Arsenites; Biological Assay; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Disulfides; Ethanol; Etoposide; Humans; Hydrogen Peroxide; Hypoxia; Radiation, Ionizing; Toxicity Tests | 2012 |
Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Carrier Proteins; Cell Line, Tumor; DNA-Binding Proteins; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Nude; Neoplasms; Nuclear Proteins; Nucleic Acid Synthesis Inhibitors; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Transcription Factors; Transplantation, Heterologous | 2004 |
Phosphorylated histone H2AX in spheroids, tumors, and tissues of mice exposed to etoposide and 3-amino-1,2,4-benzotriazine-1,3-dioxide.
Topics: Animals; Antineoplastic Agents; Cell Survival; DNA Damage; Etoposide; Female; Flow Cytometry; Histones; Humans; Hypoxia; Kidney; Mice; Mice, Inbred NOD; Mice, SCID; Phosphorylation; Spheroids, Cellular; Spleen; Tirapazamine; Transplantation, Heterologous; Triazines; Tumor Stem Cell Assay; Uterine Cervical Neoplasms | 2004 |
Life-threatening airway obstruction caused by mediastinal germinoma in a 9-year-old girl.
Topics: Airway Obstruction; Anesthesia, General; Antineoplastic Combined Chemotherapy Protocols; Asphyxia; Asthma; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Contraindications; Diagnostic Errors; Dyspnea; Emergencies; Epilepsy, Generalized; Etoposide; Female; Germinoma; Humans; Hypoxia; Mediastinal Neoplasms; Radiotherapy, Adjuvant; Remission Induction; Tomography, X-Ray Computed; Tracheal Stenosis | 2005 |
Acquisition of anoikis resistance in human osteosarcoma cells does not alter sensitivity to chemotherapeutic agents.
Topics: Anoikis; Antineoplastic Agents; Apoptosis; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Separation; Cell Survival; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Extracellular Matrix; Flow Cytometry; Humans; Hypoxia; Neoplasm Metastasis; Osteosarcoma; Paclitaxel; Propidium; Vinblastine | 2005 |
WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53.
Topics: Active Transport, Cell Nucleus; Animals; Anisomycin; Cell Line, Tumor; Cell Nucleus; Cytoplasm; Cytosol; DNA, Complementary; Dose-Response Relationship, Drug; Etoposide; Fibroblasts; Genes, Dominant; Humans; Hypoxia; Imidazoles; Immunoprecipitation; Luminescent Proteins; Mice; Microscopy, Fluorescence; Models, Biological; Oxidoreductases; Phosphorylation; Piperazines; Proteasome Endopeptidase Complex; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serine; Staurosporine; Time Factors; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Two-Hybrid System Techniques; Tyrosine; U937 Cells; Ultraviolet Rays; WW Domain-Containing Oxidoreductase | 2005 |
Hypoxia confers protection against apoptosis via PI3K/Akt and ERK pathways in lung cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Enzyme Inhibitors; Etoposide; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Humans; Hypoxia; Lung Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Ultraviolet Rays | 2006 |
Suppression of hypoxic cell death by APIP-induced sustained activation of AKT and ERK1/2.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptotic Protease-Activating Factor 1; Caspase 9; Caspases; Cells, Cultured; Electrophoresis, Gel, Two-Dimensional; Enzyme Activation; Etoposide; Humans; Hypoxia; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction | 2007 |
Purging of the neuroblastoma stem cell compartment and tumor regression on exposure to hypoxia or cytotoxic treatment.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Clone Cells; Electrophysiology; Etoposide; Humans; Hypoxia; Immunohistochemistry; Neoplastic Stem Cells; Neuroblastoma | 2007 |
Chemotherapy-induced interstitial pneumonitis during treatment of small cell anaplastic lung cancer.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Biopsy; Cyclophosphamide; Etoposide; Female; Humans; Hypoxia; Lung Neoplasms; Male; Methotrexate; Middle Aged; Pulmonary Fibrosis; Serologic Tests | 1984 |
Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs.
Topics: Acetylcysteine; Animals; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Northern; Cell Cycle; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Glucose; Humans; Hypoxia; Immunoblotting; Isoenzymes; Methotrexate; Mice; Mice, Nude; Multienzyme Complexes; Neoplasm Transplantation; Nucleic Acid Synthesis Inhibitors; Proteasome Endopeptidase Complex; Time Factors; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Vincristine | 2000 |
Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U-937 human promonocytic cells. The role of intracellular oxidation.
Topics: Adenosine Triphosphate; Alkylating Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Buthionine Sulfoximine; Camptothecin; Cell Death; Cisplatin; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Doxorubicin; Enzyme Inhibitors; Etoposide; Flow Cytometry; Glutathione; Humans; Hydrogen Peroxide; Hypoxia; Immunoblotting; Melphalan; Membrane Potentials; Mitochondria; Monocytes; Necrosis; Nucleic Acid Synthesis Inhibitors; Oxygen; Radiation-Protective Agents; Reactive Oxygen Species; Spectrometry, Fluorescence; Time Factors; Topoisomerase I Inhibitors; U937 Cells | 2001 |
Prostaglandin A1 inhibits stress-induced NF-kappaB activation and reverses resistance to topoisomerase II inhibitors.
Topics: Animals; Blotting, Western; Brefeldin A; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Humans; Hypoxia; Luciferases; Mice; NF-kappa B; Prostaglandins A; Teniposide; Time Factors; Topoisomerase II Inhibitors; Transfection; Tumor Cells, Cultured | 2000 |
The non-ankyrin C terminus of Ikappa Balpha physically interacts with p53 in vivo and dissociates in response to apoptotic stress, hypoxia, DNA damage, and transforming growth factor-beta 1-mediated growth suppression.
Topics: Animals; Ankyrins; Apoptosis; Cell Division; Cell Line; Cell Nucleus; COS Cells; Cytosol; DNA Damage; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Etoposide; Genes, Dominant; Humans; Hyaluronoglucosaminidase; Hypoxia; I-kappa B Proteins; Liver; Mice; Microscopy, Fluorescence; Mutagenesis, Site-Directed; NF-KappaB Inhibitor alpha; Phosphorylation; Precipitin Tests; Proline; Protein Binding; Protein Structure, Tertiary; Rats; Recombinant Proteins; Serine; Spleen; Staurosporine; Threonine; Time Factors; Transfection; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Ultraviolet Rays | 2002 |
Resistance to etoposide induced by three glucose-regulated stresses in Chinese hamster ovary cells.
Topics: Animals; Calcimycin; Cricetinae; Cricetulus; Dactinomycin; Deoxyglucose; Doxorubicin; Drug Resistance; Etoposide; Female; HSP70 Heat-Shock Proteins; Hypoxia; Membrane Proteins; Ovarian Neoplasms; Tumor Cells, Cultured; Vincristine | 1989 |